Douglas Freeman is a partner at Goodwin and a member of the firm’s Private Equity group. Mr. Freeman’s practice focuses on representing public and private companies, private equity firms and investment banking firms in connection with mergers, acquisitions, public offerings and other corporate transactions in a wide variety of industries. His M&A practice focuses on cross-border mergers, acquisitions, reorganizations and other business combination transactions, with broad experience in leveraged buyouts, listed company transactions and hostile or contested control transactions. Mr. Freeman has been active in a number of “going-private” transactions involving China-based companies listed in the U.S. He also represents issuers and selling shareholders in public offerings of equity and debt securities and private placements, including Rule 144A transactions, and buyers and sellers in connection with in- and out-of-court reorganizations, workouts and restructurings, including distressed mergers, acquisitions and divestitures.

傅德良律师是高赢国际律师事务所的合伙人,同时为私募股权部的一员。傅律师主要专注于代表公众公司和私营公司、私募股权公司和投资银行处理各行各业的合并、收购、公开募股和其他公司交易。傅律师的并购业务专注于跨境兼并、收购、重组和其他业务合并交易,在杠杆收购,上市公司交易以及敌意或有争议的控制交易方面拥有丰富的经验。傅律师一直积极参与一系列涉及在美国上市的中资公司的“私有化”交易。傅德良律师也代表公开发售股权和债务证券以及私募配售 (包括按美国证券法第144A条进行的交易) 中的发行人及售股股东,以及法庭内和法庭外的重组、债务重组 (包括财困企业合并、收购、分拆) 中的买方和卖方。

Areas of Practice
Domaines D’Expertise





Mr. Freeman has served as counsel to:

  • The management of ELEVATE in the sale of ELEVATE, an industry leader in ESG and supply chain services globally, by the Elevate management team and EQT to LRQA.
  • FountainVest Partners in connection with its $900 million acquisition of Beijing Zhendong Langdi Pharmaceutical Co., Ltd. 
  • FountainVest Partners on the acquisition of CFB Group, a China-based multi-brand food and beverage platform operator that is world’s largest franchisee of Dairy Queen and one of the largest franchisees of Papa John’s Pizza outside of the United States
  • PTK Acquisition Corp. in its $1.1 billion business combination with Valens Semiconductor
  • FountainVest Partners in connection with its acquisition of China-based logistics enterprise CJ Rokin Logistics and Supply Chain 
  • LionRock Capital in connection with its acquisition of a majority stake in leading shoe manufacturer and retailer Clarks
  • FountainVest Partners in a number of significant Greater China transactions, including its investments in 360 Finance, Laobaixing Pharmacy, Maoyan Entertainment, Meituan-Dianping, and
  • LionRock Capital in connection with its investment in the football club Inter Milan
  • FountainVest Partners in the sale of its interests in Focus Media, a leading digital marketing company listed on the Shenzhen Stock Exchange, to the Alibaba Group
  • FountainVest Partners in its China joint venture with WME | IMG, a global sports, fashion and entertainment talent management company, together with Sequoia Capital China and Tencent
  • FountainVest Partners, and its portfolio company, Trusted Doctors, in its merger with Tencent Doctorwork, a medical unit of Tencent Holdings
  • TKK Symphony in the de-SPAC acquisition of Glory Star New Media Group, a leading mobile entertainment platform in China
  • FountainVest Partners in connection with its going private acquisition of Chinese online career platform Zhaopin Limited, together with Hillhouse Capital and SEEK International*
  • the buyer group consortium (consisting of Carlyle, FountainVest Partners, CITIC Capital, Everbright, Fosun International, and the Chairman) in the US$3.7 billion acquisition of Focus Media Holding Limited (NASDAQ: FMCN). The going-private transaction is China’s largest leveraged buyout in history.*
  • Co-investment fund formed by Focus Media and FountainVest Partners in connection with investments in the sports, media and entertainment industries*
  • ZQ Capital in its acquisition of Angiotech Pharmaceuticals, Inc., a medical device manufacturer, and its $210 million PIPE investment in NYSE-listed Nu Skin Enterprises*
  • AEA in connection with its acquisition of Three-Sixty Group*
  • Goldman Sachs as financial adviser to the Special Committee of AsiaInfo-Linkage (NASDAQ: ASIA) in the US$890 million acquisition by a consortium led by CITIC Capital Partners*
  • Goldman Sachs as financial adviser to the Special Committee of iSoftStone Holdings Limited (NYSE: ISS) in a pending going private transaction*
  • Goldman Sachs in connection with several principal investments*
  • Lazard as financial adviser to the Special Committee of AutoNavi Holdings Limited in a going private transaction.*
  • Lazard as financial adviser to a buyer group in its acquisition of Yucheng Technologies Limited (NASDAQ: YTEC)*
  • Houlihan Lokey as financial adviser to numerous companies
  • Duffs & Phelps as financial adviser to numerous companies
  • the private equity buyer consortium in its going-private acquisition of China jewelry retailer and distributor NASDAQ-listed LJ International*
  • Special Committee of CNinsure (NASDAQ: CISG) in connection with a proposed US$950 million going private transaction involving its chairman and private equity sponsors, including TPG*
  • the independent directors of ChinaCast Education Group (NASDAQ: CAST) in connection with its review of strategic alternatives and crisis management issues*
  • the independent directors of Acorn International (NYSE: ATV), a China-based TV retailer, in connection with its consideration of an unsolicited partial tender offer by its co-founders*
  • Tiens Group, the controlling shareholder of NYSE-listed Tiens Biotech, a China-based manufacturer and distributor of nutritional supplements, in connection with a going private transaction*
  • the Special Committee of Board of Directors of NASDAQ-listed Solarfun Power Holdings, a solar cell producer, in connection with its US$370 million sale of a controlling stake to Hanwha Corporation*
  • a consortium consisting of Sequoia Capital, Citic Capital, and FountainVest Partners in connection with a management-led US$180 million investment in SINA Corporation*

* Denotes experience prior to joining Goodwin.

  • 代表全球ESG和供应链服务领域的行业领导者ELEVATE 管理团队,向 EQT 和LRQA 出售ELEVATE业务。
  • 代表方源资本收购总部位于中国的多品牌餐饮平台运营商 CFB 集团。CFB 集团是冰雪皇后(Dairy Queen)全球最大的特许加盟店经营商,也是棒约翰(Papa John’s Pizza)美国以外最大的特许加盟店经营商之一。
  • 代表方源资本以9亿美元收购北京振东朗迪制药有限公司。
  • 代表PTK Acquisition Corp.与Valens半导体合并上市,估值11.6亿美元。
  • 代表方源资本收购中国物流企业希杰荣庆物流供应链有限公司(CJ Rokin Logistics and Supply Chain)。
  • 代表莱恩资本收购领先鞋类制造商和零售商Clarks的多数股权。
  • 代表方源资本处理其在大中华地区的多项投资,包括对360金融、老百姓大药房、猫眼娱乐、美团点评和房多多等的投资。
  • 代表莱恩资本对国际米兰(Inter Milan)足球俱乐部进行投资。
  • 代表方源资本向阿里巴巴集团出售其持有的分众传媒(一家在深圳证券交易所上市的领先数字营销公司)的权益。
  • 代表方源资本联合红杉资本和腾讯与全球体育、时尚和娱乐经纪公司WME-IMG在中国设立合资公司。
  • 代表方源资本及其投资组合公司杏仁医生(Trusted Doctors)与腾讯控股旗下医疗子公司企鹅医生(Tencent Doctorwork)进行合并。
  • 代表TKK Symphony收购中国知名移动娱乐服务商耀世星辉媒体集团控股。
  • 代表方源资本,处理其联合高瓴资本及SEEK International对中国招聘网站智联招聘进行私有化的交易。*
  • 为买方银团(由凯雷、方源资本、中信资本、光大控股、复星国际和公司主席组成)提供咨询服务,协助处理其作价37亿美元收购分众传媒控股有限公司(纳斯达克上市代号:FMCN)的事宜。此私有化交易是中国历来最大型的杠杆收购。*
  • 代表分众传媒与方源资本成立的共同投资基金,处理其在运动、传媒和娱乐行业的投资交易。*
  • 代表倍哲资本处理其收购医疗器械制造商Angiotech Pharmaceuticals的交易,以及其对纽约上市的如新企业(Nu Skin Enterprises)进行的私人投资公开股票(PIPE)交易。*
  • 代表安盈投资处理其收购ThreeSixty Group的交易。*
  • 代表亚信联创(纳斯达克上市代号:ASIA) 特别委员会的财务顾问高盛公司,协助其处理由中信资本牵头的财团作价8.9亿美元对亚信联创进行的收购。*
  • 代表软通动力信息技术(集团)有限公司特别委员会的财务顾问高盛公司,协助其处理软通动力的私有化(纽约上市代号:ISS)交易。*
  • 代表高盛公司进行多项主要交易。*
  • 代表高德控股有限公司特别委员会瑞德集团处理高德控股的私有化交易。*
  • 为担任买方集团财务顾问的瑞德集团提供咨询服务,协助其处理买方集团收购宇信易诚科技有限公司(纳斯达克上市代号:YTEC)的事宜。*
  • 为作为多家公司的财务顾问的华利安诺基提供法律咨询。
  • 为作为多家公司的财务顾问的道衡提供法律咨询。
  • 代表私募股权银团,协助其处理私有化于纳斯达克上市的中资珠宝零售商和分销商LJ国际有限公司的事宜。*
  • 代表泛华保险服务(纳斯达克上市代号:CISG) 特别委员会,协助处理拟进行并涉及其董事长及私募股权保荐人 (包括德州太平洋集团 (TPG)) 的私有化交易,价值9.5亿美元。*
  • 代表双威教育集团(纳斯达克上市代号:CAST) 的独立董事,协助其审核可供选择的数个战略性方案和危机管理事宜。*
  • 为中资电视营销商橡果国际(纽约上市代号:ATV)独立董事会提供咨询服务,协助该公司处理其考虑是否接受由其共同创办人主动提出的部分收购要约。*
  • 代表天狮集团(于纽约上市的中资营养补充品制造商和分销商天狮生化的控股股东)处理天狮生化的私有化交易。*
  • 代表纳斯达克上市的太阳能电池制造商林洋新能源控股特别委员会,协助其处理向韩华集团作价3.7亿美元出售控股股权的事宜。*
  • 为红杉资本、中信资本及方源资本提供咨询服务,协助处理其对新浪公司进行的1.8亿美元投资。*



Ranked for excellence by Chambers Asia-Pacific for Private Equity: Buyouts & Venture Capital Investment (China)

Named to the China Business Law Journal’s 2020 A List China’s Elite 100 Lawyers (Foreign Firm)

Recognized by Legal 500 Asia Pacific in Corporate M&A, as a Leading Lawyer



荣登《中国商法》2020年度“A-List 法律精英”100 位外资律所优秀律师榜单


In The News









J.D., 1995
Harvard Law School
(cum laude)
B.A., 1992
Tufts University
(summa cum laude)


法学博士, 1995
文学学士, 1992
Tufts University



Registered Foreign Lawyer, Hong Kong SAR
New York



Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique